Parallel Advisors LLC Has $17.47 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Parallel Advisors LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 34,536 shares of the healthcare conglomerate’s stock after selling 2,102 shares during the quarter. Parallel Advisors LLC’s holdings in UnitedHealth Group were worth $17,471,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Cibc World Markets Corp grew its stake in shares of UnitedHealth Group by 4.2% in the fourth quarter. Cibc World Markets Corp now owns 418,371 shares of the healthcare conglomerate’s stock worth $211,637,000 after purchasing an additional 16,984 shares during the last quarter. Arbor Capital Management Inc. ADV grew its position in shares of UnitedHealth Group by 3.8% in the 4th quarter. Arbor Capital Management Inc. ADV now owns 2,484 shares of the healthcare conglomerate’s stock valued at $1,335,000 after buying an additional 91 shares during the last quarter. IMG Wealth Management Inc. bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $177,000. GLOBALT Investments LLC GA increased its position in UnitedHealth Group by 45.6% during the 4th quarter. GLOBALT Investments LLC GA now owns 18,793 shares of the healthcare conglomerate’s stock valued at $9,507,000 after purchasing an additional 5,890 shares during the period. Finally, Signature Wealth Management Group lifted its position in shares of UnitedHealth Group by 2.7% in the 4th quarter. Signature Wealth Management Group now owns 3,724 shares of the healthcare conglomerate’s stock worth $1,884,000 after purchasing an additional 97 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on UNH shares. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays lowered their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

UNH opened at $488.52 on Monday. The firm has a 50-day moving average price of $511.36 and a 200-day moving average price of $549.80. The company has a market capitalization of $446.85 billion, a price-to-earnings ratio of 31.52, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the firm posted $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.72%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.